ONVO has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ONVO has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Days Inventory is also known as Days Sales of Inventory (DSI). Organovo Holdings's Average Total Inventories for the three months ended in Dec. 2023 was $0.00 Mil. Organovo Holdings's Cost of Goods Sold for the three months ended in Dec. 2023 was $0.00 Mil.
The historical rank and industry rank for Organovo Holdings's Days Inventory or its related term are showing as below:
During the past 12 years, Organovo Holdings's highest Days Inventory was 545.27. The lowest was 168.76. And the median was 375.49.
Organovo Holdings's Days Inventory stayed the same from Dec. 2022 (0.00) to Dec. 2023 (0.00).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Organovo Holdings's Inventory-to-Revenue for the three months ended in Dec. 2023 was 0.00.
The historical data trend for Organovo Holdings's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Organovo Holdings Annual Data | |||||||||||||||||||||
Trend | Mar14 | Mar15 | Mar16 | Mar17 | Mar18 | Mar19 | Mar20 | Mar21 | Mar22 | Mar23 | |||||||||||
Days Inventory | Get a 7-Day Free Trial | 504.34 | 545.27 | - | - | - |
Organovo Holdings Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Days Inventory | Get a 7-Day Free Trial | - | - | - | - | - |
For the Biotechnology subindustry, Organovo Holdings's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Organovo Holdings's Days Inventory distribution charts can be found below:
* The bar in red indicates where Organovo Holdings's Days Inventory falls into.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Organovo Holdings's Days Inventory for the fiscal year that ended in Mar. 2023 is calculated as
Days Inventory (A: Mar. 2023 ) | |||||||||
= | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Total Inventories (A: Mar. 2022 ) | + | Total Inventories (A: Mar. 2023 )) | / | count ) | / | Cost of Goods Sold (A: Mar. 2023 ) | * | Days in Period |
= | ( (0 | + | 0) | / | 1 ) | / | 0 | * | 365 |
= | 0 | / | 0 | * | 365 | ||||
= | N/A |
Organovo Holdings's Days Inventory for the quarter that ended in Dec. 2023 is calculated as:
Days Inventory (Q: Dec. 2023 ) | |||||||||
= | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Total Inventories (Q: Sep. 2023 ) | + | Total Inventories (Q: Dec. 2023 )) | / | count ) | / | Cost of Goods Sold (Q: Dec. 2023 ) | * | Days in Period |
= | ( (0 | + | 0) | / | 1 ) | / | 0 | * | 365 / 4 |
= | 0 | / | 0 | * | 365 / 4 | ||||
= | N/A |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Organovo Holdings (NAS:ONVO) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Organovo Holdings's Inventory Turnover for the three months ended in Dec. 2023 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Organovo Holdings's Inventory to Revenue for the three months ended in Dec. 2023 is calculated as
Inventory-to-Revenue | = | Average Total Inventories | / | Revenue |
= | 0 | / | 0.005 | |
= | 0.00 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Thank you for viewing the detailed overview of Organovo Holdings's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
David Gobel | director | 440 STEVENS AVENUE, SUITE 200, SOLANA BEACH CA 92075 |
Vaidehi Joshi | director | C/O ORGANOVO HOLDINGS, INC., 11555 SORRENTO VALLEY ROAD, SUITE 100, SAN DIEGO CA 92121 |
Alison Tjosvold Milhous | director | 440 STEVENS AVENUE, SUITE 200, SOLANA BEACH CA 92075 |
Adam K Stern | director | STERN AEGIS VENTURES, 810 7TH AVENUE 22ND FLOOR, NEW YORK NY 10019 |
Thomas Hess | officer: President, CFO and PFO | 366 MADISON AVE. 12TH FLOOR, NEW YORK NY 10017 |
Douglas Jay Cohen | director | 440 STEVENS AVENUE, SUITE 200, SOLANA BEACH CA 92075 |
Thomas E Jurgensen | officer: General Counsel & Secretary | 440 STEVENS AVENUE, SUITE 200, SOLANA BEACH CA 92075 |
Jeffrey N. Miner | officer: Chief Scientific Officer | 440 STEVENS AVENUE, SUITE 200, SOLANA BEACH CA 92075 |
Chris Heberlig | officer: President and CFO | C/O KINIKSA PHARMACEUTICALS, LTD., CLARENDON HOUSE, 2 CHURCH STREET, HAMILTON D0 HM11 |
Keith Murphy | director, officer: Executive Chairman | 6275 NANCY RIDGE DRIVE, SUITE 110, SAN DIEGO CA 92121 |
Steven George Hughes | officer: Chief Medical Officer | 6275 NANCY RIDGE DRIVE, SAN DIEGO CA 92121 |
Carolyn Beaver | director | 3595 JOHN HOPKINS COURT, SAN DIEGO CA 92121 |
David Shapiro | director | C/O INTERCEPT PHARMACEUTICALS, INC., 18 DESBROSSES ST., NEW YORK NY 10013 |
Presnell Sharon Collins | officer: EVP, Research & Development | 6275 NANCY RIDGE DRIVE, SUITE 110, SAN DIEGO CA 92121 |
Taylor Crouch | director, officer: CEO & President | 440 STEVENS AVENUE, SUITE 200, SOLANA BEACH CA 92075 |
From GuruFocus
By Business Wire Business Wire • 04-01-2020
By Marketwired Marketwired • 03-23-2020
By GuruFocusNews GuruFocusNews • 05-17-2022
By Marketwired Marketwired • 03-31-2020
By GuruFocusNews GuruFocusNews • 02-02-2022
By Marketwired • 09-08-2023
By GuruFocusNews GuruFocusNews • 11-30-2021
By Business Wire Business Wire • 03-28-2020
By GuruFocusNews GuruFocusNews • 02-18-2022
By sperokesalga sperokesalga • 03-21-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.